» Articles » PMID: 35832109

The Role of Acupuncture for Long COVID: Mechanisms and Models

Overview
Journal Med Acupunct
Date 2022 Jul 14
PMID 35832109
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To establish an evidence-based role for acupuncture as a safe and effective treatment for managing Long COVID in the integrative medical setting.

Background: COVID-19 progresses to a chronic state, termed Long COVID, in about 30% of cases with estimates as high as 40% for prolonged illness. Symptoms are diverse and range over several body systems, including unrelenting fatigue, persistent malaise, chronic pain, and mood changes. Early clinical reports suggest acupuncture can effectively address both symptoms and the underlying causes of Long COVID.

Evidence: Historically, acupuncture is well defined in Traditional Chinese Medicine writings to treat influenza-like febrile illnesses. Contemporary scientific literature and case studies support the value of acupuncture for symptoms associated with acute and chronic respiratory viral infections, such as influenza, including SARS and COVID-19. Recent reports provide early evidence of acupuncture's effectiveness in managing Long COVID symptoms and may also have disease-modifying benefits.

Conclusion: Acupuncture is a viable adjunctive health care modality as part of a multidisciplinary approach for symptom control and disease management to improve quality of life in Long COVID patients. Since acupuncture may favorably modify the length and outcome of this condition, the model of acupuncture presented in this article warrants broader use in the integrative clinical setting and for further research.

Citing Articles

The use of acupuncture for addressing neurological and neuropsychiatric symptoms in patients with long COVID: a systematic review and meta-analysis.

Lam W, Wei D, Li H, Yao L, Zhang S, Lai M Front Neurol. 2024; 15:1406475.

PMID: 39099786 PMC: 11294104. DOI: 10.3389/fneur.2024.1406475.


Multidisciplinary Management Strategies for Long COVID: A Narrative Review.

Prusinski C, Yan D, Klasova J, McVeigh K, Shah S, Fermo O Cureus. 2024; 16(5):e59478.

PMID: 38826995 PMC: 11142761. DOI: 10.7759/cureus.59478.


Recommendations and guidelines of integrative medicine for COVID-19 care: The APEC project outcome.

Jia L, Beidelschies M, Evans J, Niemtzow R, Niemtzow S, Dusek J Integr Med Res. 2024; 13(1):101022.

PMID: 38434793 PMC: 10907161. DOI: 10.1016/j.imr.2024.101022.


Efficacy and safety of acupuncture treatment for fatigue after COVID-19 infection: study protocol for a pilot randomized sham-controlled trial.

Kim S, Lee J, Kim T, Kim T, Kwon S, Kang J Front Neurol. 2023; 14:1302793.

PMID: 38033774 PMC: 10684676. DOI: 10.3389/fneur.2023.1302793.


Acupuncture as an Additional Method of Rehabilitation Post-COVID-19: a randomized controlled trial.

Omarova I, Akanova A, Kurmanova A, Kurmanova G, Glushkova N, Seidanova A J Pharmacopuncture. 2023; 26(3):238-246.

PMID: 37799621 PMC: 10547817. DOI: 10.3831/KPI.2023.26.3.238.


References
1.
Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

2.
Volf N, Salques V, Lassaux A . An Auricular Marker for COVID-19. Med Acupunct. 2020; 32(4):174-175. PMC: 7464934. DOI: 10.1089/acu.2020.29151.vlf. View

3.
Jones S, Hunter C . Is IL-6 a key cytokine target for therapy in COVID-19?. Nat Rev Immunol. 2021; 21(6):337-339. PMC: 8043092. DOI: 10.1038/s41577-021-00553-8. View

4.
Liu Z, Li J, Chen D, Gao R, Zeng W, Chen S . Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19. Front Pharmacol. 2020; 11:1093. PMC: 7379481. DOI: 10.3389/fphar.2020.01093. View

5.
Stefano G, Buttiker P, Weissenberger S, Martin A, Ptacek R, Kream R . Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis. Med Sci Monit. 2021; 27:e933015. PMC: 8120907. DOI: 10.12659/MSM.933015. View